InvestorsHub Logo
Followers 103
Posts 16378
Boards Moderated 0
Alias Born 07/29/2011

Re: None

Friday, 09/30/2016 10:53:33 AM

Friday, September 30, 2016 10:53:33 AM

Post# of 77155
Excellent Leadership EAPH! Exclusive signed contracts for Women's Health Products for Mexico and most Latin American Countries may just end up being one of the most significant Women's Health arrangements in the regions history. Very exciting for shareholders and a solid opening for these markets IMO.
"Easton Pharmaceuticals Announces Receiving Mexican Regulatory Approval for VagiSan (VS-Sense) Diagnostic Device, in Support of On-Going Exclusive Distribution Negotiations With Multi-National Pharmaceutical Companies for Major Latin American Markets."